Eli Lil­ly los­es case against Flori­da com­pound­ing phar­ma­cy

Eli Lil­ly suf­fered an­oth­er loss this week in its le­gal cam­paign against com­pound­ed ver­sions of its pop­u­lar di­a­betes and weight loss drug tirzepatide.

A Flori­da fed­er­al judge tossed Lil­ly’s law­suit against a Mi­a­mi com­pound­ing phar­ma­cy on Wednes­day, rul­ing that Lil­ly can’t “use state law as a back door to pri­vate­ly en­force” the Fed­er­al Food, Drug, and Cos­met­ic Act (FD­CA). The de­ci­sion comes just a cou­ple months af­ter an­oth­er Flori­da judge dis­missed a sep­a­rate case Lil­ly brought against a dif­fer­ent com­pound­ing phar­ma­cy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER